Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-2020/asco-2020-prostate-cancer/121828-asco-2020-first-in-human-phase-1-study-of-arv-110-an-androgen-receptor-protac-degrader-in-patients-with-metastatic-castration-resistant-prostate-cancer-following-enzalutamide-and-or-abiraterone-acetate-treatment.html
If you do not want to visit that page, you can close this browser tab.
